| SC 13G/A | 2024-02-14 | Rock Springs Capital Management LP | AGIOS PHARMACEUTICALS, INC. | 2,152,173 | 3.8% | EDGAR |
| SC 13G/A | 2024-02-14 | ARMISTICE CAPITAL, LLC | AGIOS PHARMACEUTICALS, INC. | 3,524,000 | 6.3% | EDGAR |
| SC 13G/A | 2024-02-13 | BB BIOTECH AG | AGIOS PHARMACEUTICALS, INC. | 4,000,000 | 7.2% | EDGAR |
| SC 13G/A | 2024-02-12 | VANGUARD GROUP INC | AGIOS PHARMACEUTICALS, INC. | 5,527,438 | 9.9% | EDGAR |
| SC 13G/A | 2024-02-12 | VANGUARD GROUP INC | AGIOS PHARMACEUTICALS, INC. | 5,599,917 | 10.0% | EDGAR |
| SC 13G/A | 2024-02-08 | Farallon Capital Partners, L.P. | AGIOS PHARMACEUTICALS, INC. | 350,343 | 0.6% | EDGAR |
| SC 13G/A | 2024-01-25 | BlackRock Inc. | AGIOS PHARMACEUTICALS, INC. | 4,962,237 | 8.9% | EDGAR |
| SC 13G/A | 2024-01-22 | STATE STREET CORP | AGIOS PHARMACEUTICALS, INC. | - | 4.7% | EDGAR |
| SC 13G/A | 2023-11-09 | WELLINGTON MANAGEMENT GROUP LLP | AGIOS PHARMACEUTICALS, INC. | 2,200,757 | 4.0% | EDGAR |
| SC 13G | 2023-11-09 | Farallon Capital Partners, L.P. | AGIOS PHARMACEUTICALS, INC. | 332,366 | 0.6% | EDGAR |
| SC 13G/A | 2023-04-10 | WELLINGTON MANAGEMENT GROUP LLP | AGIOS PHARMACEUTICALS, INC. | 5,723,131 | 10.4% | EDGAR |
| SC 13G/A | 2023-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | AGIOS PHARMACEUTICALS, INC. | 1,480,194 | 2.7% | EDGAR |
| SC 13G/A | 2023-02-14 | BB BIOTECH AG | AGIOS PHARMACEUTICALS, INC. | 4,030,792 | 7.3% | EDGAR |
| SC 13G | 2023-02-14 | ARMISTICE CAPITAL, LLC | AGIOS PHARMACEUTICALS, INC. | 2,750,000 | 5.0% | EDGAR |
| SC 13G | 2023-02-14 | Rock Springs Capital Management LP | AGIOS PHARMACEUTICALS, INC. | 2,996,592 | 5.4% | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | AGIOS PHARMACEUTICALS, INC. | 5,335,076 | 9.7% | EDGAR |
| SC 13G/A | 2023-02-08 | STATE STREET CORP | AGIOS PHARMACEUTICALS, INC. | - | 5.8% | EDGAR |
| SC 13G/A | 2023-02-06 | WELLINGTON MANAGEMENT GROUP LLP | AGIOS PHARMACEUTICALS, INC. | 5,462,657 | 9.9% | EDGAR |
| SC 13G/A | 2023-01-25 | BlackRock Inc. | AGIOS PHARMACEUTICALS, INC. | 4,768,874 | 8.7% | EDGAR |
| SC 13G/A | 2022-10-06 | JPMORGAN CHASE & CO | AGIOS PHARMACEUTICALS, INC. | 1,491,001 | 2.7% | EDGAR |